Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Epoetin Alfa in Aneurysmal Subarachnoid Hemorrhage
NCT00626574Phase 4Terminated
- Sponsor
- University of South Florida
- Start
- Jul 2007
- Primary completion
- Feb 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin alfa in aneurysmal subarachnoid hemorrhage (SAH), sponsored by University of South Florida. Started Jul 2007; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00626574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626574.